Cure My Disease

Don't miss your cure!

 Log in / Sign up

A virtual clinic for lewy body dementia: could telehealth break down barriers to care?

NCT ID NCT05014971

Disease control Sponsor: University of Florida Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether delivering interdisciplinary care via video telehealth can improve access and satisfaction for people with Lewy body dementia (LBD) and their caregivers. Participants receive remote consultations with a team of specialists, including a neurologist, therapists, a social worker, and a dietician. The study measures how feasible this approach is and whether participants are satisfied with the care they receive.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tele-neurohub: interdisciplinary care delivered via video telemedicine, including neurologist, physical, occupational and speech therapy, social worker, and dietician.
What this could lead to
If successful, this could establish a practical model for delivering comprehensive, interdisciplinary dementia care remotely, improving access for patients in rural or underserved areas.
What could go wrong
The trial is relatively small and focuses on feasibility and satisfaction, not long-term health outcomes. Results may not generalize to all LBD patients, and technology or caregiver burden could limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 106 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2022

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participant with Lewy Body Dementia (LBD) Inclusion Criteria: * LBD diagnosis by a dementia or movement disorders specialist * Clinician-determined mild-moderate dementia severity * Internet access with a Zoom-compatible device * Caregiver who resides in the patient's home and is willing to participate * Fluency in English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lewy body dementia with behavioral disturbance are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lewy body dementia Lewy Body Disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lewy body dementia with behavioral disturbance Lewy body disease Lewy body Parkinson disease

Contacts and locations

Locations

  • University of Florida

    Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.